Term Diagnostic Blood Tests for Children's Inflammatory Illness
Code LF-4900.1710
Definition Programs that offer tests which recognize unique blood markers for pediatric multi-system inflammatory syndrome (MSI-C), allowing doctors to diagnose children in the early stages of the illness and save lives before the child has become so seriously ill that they require intensive care.
Created 6/2/20
Changed 1/5/21
Use References Blood Marker Test for COVID-Linked Syndrome in Children
Blood Test for Pediatric Multi-System Inflammatory Syndrome
Diagnostic Tests for MSI-C
See Also References COVID-19 Antibody Test Development (JP-1500.1520)
COVID-19 Antibody Tests (LF-4900.1562)
COVID-19 Control (JP-1500.1700-150)
COVID-19 Diagnostic Tests (LF-4900.1565)
COVID-19 Immunization Clinics (LT-3400.1525)
COVID-19 Immunization Home Visits (LT-3400.1530)
COVID-19 Test Home Collection Kits (LF-4900.1567)
COVID-19 Test Results Hotlines (LF-4900.1568)
COVID-19 Treatment (LT-1750.1620)
Fraudulent COVID-19 Test/Vaccine/Treatment Reporting (FN-1700.1470-215)
Long Term COVID-19 Clinics (LT-1750.4460)
Public Health Order Violations Reporting (JP-6650)
External Classification Terms Ambulatory & Primary Health Care (NPC E09.02)
Ambulatory & Primary Health Care (NTE E30)
Chronic Disease Control (UW 2.1.01.02)
Health (CAN HC-300)
Health Care (AIRS HC-300)
Related Concepts Children and Youth
Disaster Services
Facet Service
Comments
Bibliographic References "Blood Markers Discovered for COVID-Linked Syndrome in Children", NBC News website, https://www.nbcnews.com/health/kids-health/blood-markers-discovered-covid-linked-syndrome-children-n1215546

Privacy Policy. Terms of Use. Contact 211 LA County.